BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 23868068)

  • 1. HDAC inhibition suppresses cardiac hypertrophy and fibrosis in DOCA-salt hypertensive rats via regulation of HDAC6/HDAC8 enzyme activity.
    Kee HJ; Bae EH; Park S; Lee KE; Suh SH; Kim SW; Jeong MH
    Kidney Blood Press Res; 2013; 37(4-5):229-39. PubMed ID: 23868068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding.
    Kee HJ; Sohn IS; Nam KI; Park JE; Qian YR; Yin Z; Ahn Y; Jeong MH; Bang YJ; Kim N; Kim JK; Kim KK; Epstein JA; Kook H
    Circulation; 2006 Jan; 113(1):51-9. PubMed ID: 16380549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inhibition of HDAC2 by magnesium valproate attenuates cardiac hypertrophy.
    Raghunathan S; Goyal RK; Patel BM
    Can J Physiol Pharmacol; 2017 Mar; 95(3):260-267. PubMed ID: 28177689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone deacetylase inhibition attenuates cardiac hypertrophy and fibrosis through acetylation of mineralocorticoid receptor in spontaneously hypertensive rats.
    Kang SH; Seok YM; Song MJ; Lee HA; Kurz T; Kim I
    Mol Pharmacol; 2015 May; 87(5):782-91. PubMed ID: 25667225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury.
    Noh H; Oh EY; Seo JY; Yu MR; Kim YO; Ha H; Lee HB
    Am J Physiol Renal Physiol; 2009 Sep; 297(3):F729-39. PubMed ID: 19553350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylase inhibition attenuates transcriptional activity of mineralocorticoid receptor through its acetylation and prevents development of hypertension.
    Lee HA; Lee DY; Cho HM; Kim SY; Iwasaki Y; Kim IK
    Circ Res; 2013 Mar; 112(7):1004-12. PubMed ID: 23421989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial fibrosis and diastolic dysfunction in deoxycorticosterone acetate-salt hypertensive rats is ameliorated by the peroxisome proliferator-activated receptor-alpha activator fenofibrate, partly by suppressing inflammatory responses associated with the nuclear factor-kappa-B pathway.
    Ogata T; Miyauchi T; Sakai S; Takanashi M; Irukayama-Tomobe Y; Yamaguchi I
    J Am Coll Cardiol; 2004 Apr; 43(8):1481-8. PubMed ID: 15093887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of manidipine on cardiac hypertrophy and coronary circulation in DOCA/salt hypertensive rats.
    Takeda K; Nakata T; Kuwabara T; Itoh H; Yamahara Y; Takesako T; Tanabe S; Sasaki S; Asayama J; Nakagawa M
    Blood Press Suppl; 1992; 3():48-52. PubMed ID: 1343289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emblica officinalis exerts antihypertensive effect in a rat model of DOCA-salt-induced hypertension: role of (p) eNOS, NO and oxidative stress.
    Bhatia J; Tabassum F; Sharma AK; Bharti S; Golechha M; Joshi S; Sayeed Akhatar M; Srivastava AK; Arya DS
    Cardiovasc Toxicol; 2011 Sep; 11(3):272-9. PubMed ID: 21748534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinase 2 induces epithelial-mesenchymal transition in proximal tubules from the luminal side and progresses fibrosis in mineralocorticoid/salt-induced hypertensive rats.
    Iwazu Y; Muto S; Hirahara I; Fujisawa G; Takeda S; Kusano E
    J Hypertens; 2011 Dec; 29(12):2440-53. PubMed ID: 22045122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of HDAC2 and HDAC8 in Cardiac Remodeling in Renovascular Hypertensive Rats and the Effects of Valproic Acid Sodium.
    Li RF; Cao SS; Fang WJ; Song Y; Luo XT; Wang HY; Wang JG
    Pharmacology; 2017; 99(1-2):27-39. PubMed ID: 27673327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COX-2-independent activation of renal (pro)renin receptor contributes to DOCA-salt hypertension in rats.
    Wang F; Sun Y; Luo R; Lu X; Yang B; Yang T
    Am J Physiol Renal Physiol; 2020 Oct; 319(4):F647-F653. PubMed ID: 32799674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renoprotective Effect of the Histone Deacetylase Inhibitor CG200745 in DOCA-Salt Hypertensive Rats.
    Bae EH; Kim IJ; Song JH; Choi HS; Kim CS; Eom GH; Kim I; Cha H; Cho JM; Ma SK; Kim SW
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30691015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylase inhibitor, CG200745, attenuates cardiac hypertrophy and fibrosis in DOCA-induced hypertensive rats.
    Lee E; Song MJ; Lee HA; Kang SH; Kim M; Yang EK; Lee do Y; Ro S; Cho JM; Kim I
    Korean J Physiol Pharmacol; 2016 Sep; 20(5):477-85. PubMed ID: 27610034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of C/EBPβ and TSC2 by an HDAC inhibitor CG200745 protects heart from DOCA-induced hypertrophy.
    Lee E; Lee HA; Kim M; Do GY; Cho HM; Kim GJ; Jung H; Song JH; Cho JM; Kim I
    Clin Exp Pharmacol Physiol; 2019 Mar; 46(3):226-236. PubMed ID: 30099761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Respective role of humoral factors and blood pressure in cardiac remodeling of DOCA hypertensive rats.
    Karam H; Heudes D; Hess P; Gonzales MF; Löffler BM; Clozel M; Clozel JP
    Cardiovasc Res; 1996 Feb; 31(2):287-95. PubMed ID: 8730406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy.
    Kong Y; Tannous P; Lu G; Berenji K; Rothermel BA; Olson EN; Hill JA
    Circulation; 2006 Jun; 113(22):2579-88. PubMed ID: 16735673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emodin and emodin-rich rhubarb inhibits histone deacetylase (HDAC) activity and cardiac myocyte hypertrophy.
    Evans LW; Bender A; Burnett L; Godoy L; Shen Y; Staten D; Zhou T; Angermann JE; Ferguson BS
    J Nutr Biochem; 2020 May; 79():108339. PubMed ID: 32007664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac HDAC6 catalytic activity is induced in response to chronic hypertension.
    Lemon DD; Horn TR; Cavasin MA; Jeong MY; Haubold KW; Long CS; Irwin DC; McCune SA; Chung E; Leinwand LA; McKinsey TA
    J Mol Cell Cardiol; 2011 Jul; 51(1):41-50. PubMed ID: 21539845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifibrotic activity of an inhibitor of histone deacetylases in DOCA-salt hypertensive rats.
    Iyer A; Fenning A; Lim J; Le GT; Reid RC; Halili MA; Fairlie DP; Brown L
    Br J Pharmacol; 2010 Apr; 159(7):1408-17. PubMed ID: 20180942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.